Initial Statement of Beneficial Ownership (3)

Date : 07/09/2019 @ 10:01PM
Source : Edgar (US Regulatory)
Stock : AbbVie Inc (ABBV)
Quote : 65.97  -1.55 (-2.30%) @ 12:59AM

Initial Statement of Beneficial Ownership (3)

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hudson Thomas J

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/1/2019 

3. Issuer Name and Ticker or Trading Symbol

AbbVie Inc. [ABBV]

(Last)        (First)        (Middle)

1 NORTH WAUKEGAN ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, R&D and CSO /

(Street)

NORTH CHICAGO, IL 60064       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common stock, $0.01 par value   12748   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)     (1) 5/22/2026   Common stock, $0.01 par value   14080   $59.50   D    
Option (right to buy)     (2) 2/15/2027   Common stock, $0.01 par value   15230   $61.36   D    
Option (right to buy)     (3) 2/14/2028   Common stock, $0.01 par value   6710   $114.36   D    
Option (right to buy)     (4) 2/20/2029   Common stock, $0.01 par value   15576   $79.02   D    

Explanation of Responses:
(1)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 4,694 shares on 5/23/2017, as to 4,693 shares on 5/23/2018 and as to 4,693 shares on 5/23/2019.
(2)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,077 shares on 2/16/2018 and as to 5,077 shares on 2/16/2019, and becomes exercisable as to 5,076 shares on 2/16/2020.
(3)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,237 shares on 2/15/2019, and becomes exercisable as to 2,236 shares on 2/15/2020 and as to 2,237 shares on 2/15/2021.
(4)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable as to 5,192 shares on 2/21/2020, as to 5,192 shares on 2/21/2021 and as to 5,192 shares on 2/21/2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hudson Thomas J
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064


SVP, R&D and CSO

Signatures
Steven L. Scrogham, attorney-in-fact for Thomas J. Hudson 7/9/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

AbbVie (NYSE:ABBV)
Historical Stock Chart

1 Year : From Aug 2018 to Aug 2019

Click Here for more AbbVie Charts.

AbbVie (NYSE:ABBV)
Intraday Stock Chart

Today : Saturday 24 August 2019

Click Here for more AbbVie Charts.

Latest ABBV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.